title: Pravastatin prevents primary nonfunction of canine islet autografts.
authors.affiliation: Human Islet Program, Department of Surgery, VAMC/WLA, Los Angeles, CA 90073, USA.
authors.forename: S
authors.initials: S
authors.lastname: Arita
authors.forename: T
authors.initials: T
authors.lastname: Nagai
authors.forename: M
authors.initials: M
authors.lastname: Ochiai
authors.forename: Y
authors.initials: Y
authors.lastname: Sakamoto
authors.forename: C V
authors.initials: CV
authors.lastname: Smith
authors.forename: L
authors.initials: L
authors.lastname: Shevlin
authors.forename: Y
authors.initials: Y
authors.lastname: Mullen
mesh_terms: D000818:Animals; D004285:Dogs; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects*; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D016381:Islets of Langerhans Transplantation; D017035:Pravastatin / Q000008:administration & dosage*; D014182:Transplantation, Autologous
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017035:Pravastatin